Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL8608021 | 1.00 | GLRA1 (0.91) | — | |
| Glycine SCHEMBL9474283 | 0.96 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL16603 | 0.96 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL2586660 | 0.96 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL2150066 | 0.96 | — | — | |
| Glycine SCHEMBL583141 | 0.96 | GLRA1 (0.83) | — | |
| Glycine SCHEMBL391027 | 0.95 | GLRA1 (1.00) | — | |
| Glycine SCHEMBL6163 | 0.95 | — | — | |
| Glycine SCHEMBL3640989 | 0.95 | GLRA1 (1.00) | — | |
| Glycine SCHEMBL391786 | 0.95 | GLRA1 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 566 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119797313-A | Method for preparing double-carbon modified sodium-electricity positive electrode material by utilizing waste ferric phosphate | 龙子湖新能源实验室 | 2025-04-11 | — | — | CN | claimed |
| CN-115531321-A | Amoxicillin composition, preparation method and application thereof | 广东温氏大华农生物科技有限公司 | 2022-12-30 | — | — | CN | claimed |
| US-10610596-B2 | Methods of making solid vaccine compositions having reduced foaming | ABIC BIOLOGICAL LABORATORIES LTD. (IL) | 2020-04-07 | — | — | US | claimed |
| WO-2019073321-A1 | EFFERVESCENT COMPOSITIONS COMPRISING RIFAXIMIN | ZENVISION PHARMA LLP (IN) | 2019-04-18 | — | — | WO | claimed |
| US-10188734-B2 | Reduced foaming vaccine compositions | MERIAL, INC. (US) | 2019-01-29 | — | — | US | claimed |
| WO-2018193346-A1 | EFFERVESCENT COMPOSITIONS COMPRISING CHLORPROMAZINE OR SALT THEREOF | ZENVISION PHARMA LLP (IN) | 2018-10-25 | — | — | WO | claimed |
| CN-107773696-A | A kind of pressure-reducing shower health is precious | 段工华 | 2018-03-09 | — | — | CN | claimed |
| CN-102698277-B | Drug carrier for sustained release of drug | 钟术光 | 2016-08-03 | — | — | CN | claimed |
| WO-2013100871-A1 | EFFERVESCENT RIVASTIGMINE FORMULATIONS | BILGIC MAHMUT (TR) | 2013-07-04 | — | — | WO | claimed |
| CN-101987081-B | Controlled release preparation | SHUGUANG ZHONG | 2012-08-08 | — | — | CN | claimed |
| EP-2051693-B1 | PHARMACEUTICAL COMPOSITIONS EASY TO SWALLOW, NOT CAUSING ANY UNPLEASANT ORAL SENSATION AND COMPRISING PARTICLES WITH AN ACTIVE PRINCIPLE | LOSAN PHARMA GMBH (DE) | 2010-10-13 | — | — | EP | claimed |
| CN-100445263-C | Microwave method for synthesizing carbonate of natrium glycine | UNIV SICHUAN (CN) | 2008-12-24 | — | — | CN | claimed |
| US-20070232785-A1 | Process for neutralization of the residual acidity contained in the phenolic compounds | A. WEBER (FR) | 2007-10-04 | — | — | US | claimed |
| EP-1088052-A1 | USE OF CARBON DIOXIDE AND CARBONIC ACID TO CLEAN CONTACT LENSES | Alcon Laboratories, Inc. (US) | 2001-04-04 | — | — | EP | claimed |
| US-6171404-B1 | DISINFECTING HYDROGEN PEROXIDE IN EFFERVESCENT TABLETS FOR CONTACT LENSES | ALCON LABORATORIES, INC. | 2001-01-09 | — | — | US | claimed |
| EP-0877606-B1 | EFFERVESCENT IBUPROFEN PREPARATION AND PROCESS FOR THE PRODUCTION THEREOF | LOSAN PHARMA GMBH (DE) | 2000-09-13 | — | — | EP | claimed |
| WO-1999066020-A1 | USE OF CARBON DIOXIDE AND CARBONIC ACID TO CLEAN CONTACT LENSES | ALCON LABORATORIES, INC. (US) | 1999-12-23 | — | — | WO | claimed |
| US-5909745-A | EXCLUSION OF POLYMERIC BEADS, ENZYMES, SURFACTNATS AND HYDROGEN PEROXIDE TO REDUCE LIKELINESS OF DAMAGE TO CONTACT LENSE OR EYES | ALCON LABORATORIES, INC. (US) | 1999-06-08 | — | — | US | claimed |
| EP-0293975-B1 | DRY, RAPIDLY SOLUBLE, COMPOSITIONS OF BETA-LACTAM ANTIBIOTICS | AKZO N.V. (NL) | 1991-07-24 | — | — | EP | claimed |
| EP-0063884-B1 | OXAZOLE DERIVATIVES, THEIR PREPARATION AND USE | JOHN WYETH & BROTHER LIMITED (GB) | 1985-06-26 | — | — | EP | claimed |